Furthermore, it was shown to act as a co-activator of Tal1, a key transcriptional regulator in the development of T-cell acute lymphoblastic leukaemia (Chen et al., 1990; Kolodziej et al., 2014). The gene discussed is TAL1; the disease is T-cell acute lymphoblastic leukemia.